Lannett LCI will release a FDA response to its morphine sulfate oral solution and other drug applications later today via a press release, as confirmed by a call by Benzinga to the company. Note: Lannett originally had a PDUFA date scheduled for yesterday, June 23, 2011. That revised PDUFA date announcement can be found here.
Benzinga previously alerted readers to this possibility here as of 8:37 a.m. ET.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in